Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 14(1): 7637, 2024 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-38561394

RESUMEN

Rapid placement of electric vehicle charging stations (EVCSs) is essential for the transportation industry in response to the growing electric vehicle (EV) fleet. The widespread usage of EVs is an essential strategy for reducing greenhouse gas emissions from traditional vehicles. The focus of this study is the challenge of smoothly integrating Plug-in EV Charging Stations (PEVCS) into distribution networks, especially when distributed photovoltaic (PV) systems are involved. A hybrid Genetic Algorithm and Simulated Annealing method (GA-SAA) are used in the research to strategically find the optimal locations for PEVCS in order to overcome this integration difficulty. This paper investigates PV system situations, presenting the problem as a multicriteria task with two primary objectives: reducing power losses and maintaining acceptable voltage levels. By optimizing the placement of EVCS and balancing their integration with distributed generation, this approach enhances the sustainability and reliability of distribution networks.

2.
iScience ; 27(4): 109549, 2024 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-38623328

RESUMEN

Independently run single microgrids (MGs) encounter difficulties with inadequate self-consumption of local renewable energy and frequent power exchange with the grid. Combining numerous MGs to form a multi-microgrid (MMG) is a viable approach to enhance smart distribution networks' operational and financial performance. However, the correlation and coordination of intermittent power generation within each MG network pose many techno-economic challenges for energy sharing and trading. This review offers a comprehensive analysis of these challenges within the framework of MMG operations. It examines state-of-the-art methodologies for optimizing multi-energy dispatch and scrutinizes contemporary strategies within energy markets that contribute to the resilience of power systems. The discourse extends to the burgeoning role of blockchain technology in revolutionizing decentralized market frameworks and the intricacies of MMG coordination for reliable and cost-effective energy distribution. Overall, this study provides ample inspiration for theoretical and practical research to the new entrants and experts alike to develop new concepts for energy markets, scheduling and novel operating models for future resilient multi-energy networked systems/MMGs.

3.
Sci Rep ; 14(1): 5661, 2024 Mar 07.
Artículo en Inglés | MEDLINE | ID: mdl-38454016

RESUMEN

This paper presents a cutting-edge Sustainable Power Management System for Light Electric Vehicles (LEVs) using a Hybrid Energy Storage Solution (HESS) integrated with Machine Learning (ML)-enhanced control. The system's central feature is its ability to harness renewable energy sources, such as Photovoltaic (PV) panels and supercapacitors, which overcome traditional battery-dependent constraints. The proposed control algorithm orchestrates power sharing among the battery, supercapacitor, and PV sources, optimizing the utilization of available renewable energy and ensuring stringent voltage regulation of the DC bus. Notably, the ML-based control ensures precise torque and speed regulation, resulting in significantly reduced torque ripple and transient response times. In practical terms, the system maintains the DC bus voltage within a mere 2.7% deviation from the nominal value under various operating conditions, a substantial improvement over existing systems. Furthermore, the supercapacitor excels at managing rapid variations in load power, while the battery adjusts smoothly to meet the demands. Simulation results confirm the system's robust performance. The HESS effectively maintains voltage stability, even under the most challenging conditions. Additionally, its torque response is exceptionally robust, with negligible steady-state torque ripple and fast transient response times. The system also handles speed reversal commands efficiently, a vital feature for real-world applications. By showcasing these capabilities, the paper lays the groundwork for a more sustainable and efficient future for LEVs, suggesting pathways for scalable and advanced electric mobility solutions.

4.
Sci Rep ; 14(1): 3261, 2024 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-38331946

RESUMEN

This paper proposes an innovative approach for improving the charging efficiency of electric vehicles (EVs) by combining photovoltaic (PV) systems with AC-DC Power Factor Correction (PFC). The proposed approach employs bi-directional power flow management within the PFC system, allowing for enhanced resource utilization and EV battery capacity under a variety of environmental circumstances. A modified Lyapunov-based robust model reference adaptive controller (M-LRMRAC) is developed to provide real-time Maximum Power Point Tracking (MPPT) for the PV array. By quickly recording the MPP, this controller skilfully adjusts to shifting radiation and temperature dynamics. A noteworthy accomplishment is that the M-LRMRAC outperforms traditional Perturb and Observe (P&O) techniques by achieving quick MPP convergence (0.54 s). Additionally, the benefits of this integrated system go beyond effective MPPT. The method achieves operating at unity power factor and reduces total harmonic distortion, which results in improved power quality when charging EV Batteries (EVB). The entire solution provided by this multifaceted architecture improves the quality of electricity delivered to EV batteries while also increasing energy efficiency. This research helps to the evolution of sustainable and dependable EV charging infrastructure by solving difficulties and optimising performance. The combination of PV systems with AC-DC PFC, aided by the M-LRMRAC technology, presents a viable route for attaining efficient, clean, and high-quality EV charging, hence supporting the shift to a greener and more sustainable transportation landscape.

5.
PLoS One ; 8(9): e74743, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24040333

RESUMEN

Exogenous proteolytic enzyme supplementation is required in certain disease conditions in humans and animals and due to compelling reasons on use of more plant protein ingredients and profitability in animal feed industry. However, limitations on their utility in diet are imposed by their pH specificity, thermolabile nature, inhibition due to a variety of factors and the possibility of intestinal damage. For enhancing the efficacy and safety of exogenous trypsin, an efficient chitosan (0.04%) nanoencapsulation-based controlled delivery system was developed. An experiment was conducted for 45 days to evaluate nanoencapsulated trypsin (0.01% and 0.02%) along with 0.02% bare trypsin and 0.4% chitosan nanoparticles against a control diet on productive efficiency (growth rate, feed conversion and protein efficiency ratio), organo-somatic indices, nutrient digestibility, tissue enzyme activities, hematic parameters and intestinal histology of the fish Labeo rohita. All the synthesized nanoparticles were of desired characteristics. Enhanced fish productive efficiency using nanoencapsulated trypsin over its bare form was noticed, which corresponded with enhanced (P<0.01) nutrient digestibility, activity of intestinal protease, liver and muscle tissue transaminases (alanine and aspartate) and dehydrogenases (lactate and malate), serum blood urea nitrogen and serum protein profile. Intestinal tissues of fish fed with 0.02% bare trypsin showed broadened, marked foamy cells with lipid vacuoles. However, villi were healthier in appearance with improved morphological features in fish fed with nanoencapsulated trypsin than with bare trypsin, and the villi were longer in fish fed with 0.01% nanoencapsulated trypsin than with 0.02% nanoencapsulated trypsin. The result of this premier experiment shows that nanoencapsulated trypsin mimics zymogen-like proteolytic activity via controlled release, and hence the use of 0.01% nanoencapsulated trypsin (in chitosan nanoparticles) over bare trypsin can be favored as a dietary supplement in animals and humans.


Asunto(s)
Biomimética , Quitosano/química , Suplementos Dietéticos , Precursores Enzimáticos/química , Nanopartículas/química , Tripsina/química , Albúminas/metabolismo , Alimentación Animal , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Glucemia/metabolismo , Dieta , Peces/metabolismo , Tracto Gastrointestinal/enzimología , Concentración de Iones de Hidrógeno , Mucosa Intestinal/metabolismo , Hígado/enzimología , Nitrógeno/química , Tamaño de la Partícula , Tripsina/administración & dosificación
6.
Am J Reprod Immunol ; 64(3): 179-87, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20482524

RESUMEN

PROBLEM: polymorphic changes in the IL-10 gene promoter have been identified that lead to altered IL-10 production. We hypothesized that because of these genotypic changes, the IL-10 promoter might be expressed in a cell type-specific manner and may respond differentially to inflammatory triggers. METHOD OF STUDY: we created reporter gene promoter constructs containing GCC, ACC, and ATA haplotypes using DNA from patients harboring polymorphic changes at -1082 (G→A), -819 (C→T), and -592 (C→A) sites in the IL-10 promoter. These individual luciferase reporter constructs were transiently transfected into either primary term trophoblasts or THP1 monocytic cells. DNA-binding studies were performed to implicate the role of the Sp1 transcription factor in response to differential promoter activity. RESULTS: our results suggest that the GCC promoter construct was activated in trophoblast cells in response to lipopolysaccharide (LPS), as demonstrated by reporter gene expression, but not in monocytic cells. The ACC construct showed weaker activation in both cell types. Importantly, while the ATA promoter was constitutively activated in both cell types, its expression was selectively repressed in response to LPS, but only in trophoblasts. DNA-nuclear protein binding assays with nuclear extracts from LPS treated or untreated cells suggested a functional relevance for Sp1 binding differences at the -592 position. CONCLUSIONS: these results demonstrate cell type-specific effects of the genotypic changes in the IL-10 gene promoter. These responses may be further modulated by bacterial infections or other inflammatory conditions to suppress IL-10 production in human trophoblasts.


Asunto(s)
Interleucina-10/genética , Macrófagos/metabolismo , Especificidad de Órganos , Enfermedades Placentarias/genética , Complicaciones del Embarazo/genética , Trofoblastos/metabolismo , Línea Celular , Clonación Molecular , Femenino , Haplotipos , Humanos , Interleucina-10/inmunología , Interleucina-10/metabolismo , Macrófagos/inmunología , Macrófagos/patología , Enfermedades Placentarias/inmunología , Polimorfismo Genético , Embarazo , Complicaciones del Embarazo/inmunología , Regiones Promotoras Genéticas/genética , Activación Transcripcional/inmunología , Trofoblastos/inmunología , Trofoblastos/patología
7.
Reprod Biomed Online ; 14(5): 579-87, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17509197

RESUMEN

The human TSPY (testis-specific protein, Y-linked) gene family (30-60 copies) is situated in the MSY (male-specific) region of the Y chromosome. Testis-specific expression indicates that the gene plays a role in spermatogenesis. Refined quantitative fluorescence PCR (polymerase chain reaction) was applied to evaluate the relative number of TSPY copies compared with AMELY/X (amelogenin gene, Y-linked) genes in 84 stratified infertile men and in 40 controls. A significantly higher number of TSPY copies was found in infertile men compared with the controls (P = 0.002). The diagnostic discrimination potential of the relative number of TSPY copies was evaluated by receiver operating characteristic curve analysis. TSPY/AMELY was unambiguously found to be powerful in the diagnostic separation of both the control samples and the infertile men, reaching a good level of specificity (0.642) and sensitivity (0.732) at a cut-off point of 0.46. The findings were supported by independently repeated studies of randomly selected positive samples and controls. Evaluation of the TSPY copy number offers a completely new diagnostic approach in relation to the genetic cause of male infertility. The possible effect of the copy number of TSPY genes on spermatogenesis may explain indiscrete pathological alterations of spermatid quality and quantity.


Asunto(s)
Proteínas de Ciclo Celular/genética , Dosificación de Gen , Infertilidad Masculina/genética , Espermatogénesis/genética , Adulto , Humanos , Masculino , Persona de Mediana Edad , Familia de Multigenes , Reacción en Cadena de la Polimerasa , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...